A model of the natural history of screen-detected prostate cancer, and the effect of radical treatment on overall survival

[1]  P. Walsh,et al.  Radical prostatectomy versus watchful waiting in early prostate cancer. , 2005, The Journal of urology.

[2]  James A Hanley,et al.  20-year outcomes following conservative management of clinically localized prostate cancer. , 2005, JAMA.

[3]  M. Cooperberg,et al.  The changing face of low-risk prostate cancer: trends in clinical presentation and primary management. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  Hans Lilja,et al.  Results of a randomized, population‐based study of biennial screening using serum prostate‐specific antigen measurement to detect prostate carcinoma , 2004, Cancer.

[5]  T. Tammela,et al.  Second Round Results of the Finnish Population-Based Prostate Cancer Screening Trial , 2004, Clinical Cancer Research.

[6]  D. Bostwick,et al.  Prostate cancer grade assignment: the effect of chronological, interpretive and translation bias. , 2003, The Journal of urology.

[7]  M. Cooperberg,et al.  National practice patterns and time trends in androgen ablation for localized prostate cancer. , 2003, Journal of the National Cancer Institute.

[8]  Harry J de Koning,et al.  Lead times and overdetection due to prostate-specific antigen screening: estimates from the European Randomized Study of Screening for Prostate Cancer. , 2003, Journal of the National Cancer Institute.

[9]  D Gillatt,et al.  Prostate Testing for Cancer and Treatment (ProtecT) feasibility study. , 2003, Health technology assessment.

[10]  C. Parker.  Survival prospects after screen‐detection of prostate cancer , 2003, BJU international.

[11]  E. Bergstralh,et al.  Competing risk analysis after radical prostatectomy for clinically nonmetastatic prostate adenocarcinoma according to clinical Gleason score and patient age. , 2002, Journal of Urology.

[12]  H. Frierson,et al.  Gleason scores of prostate biopsy and radical prostatectomy specimens over the past 10 years , 2002, Cancer.

[13]  Susanne Rosthøj,et al.  Competing risks as a multi-state model , 2002, Statistical methods in medical research.

[14]  T. Stamey.  Re: Pathologic features of prostate cancer found at population-based screening with a four-year interval. , 2002, Journal of the National Cancer Institute.

[15]  E. Bergstralh,et al.  Outcomes for men with clinically nonmetastatic prostate carcinoma managed with radical prostactectomy, external beam radiotherapy, or expectant management , 2001, Cancer.

[16]  T. H. van der Kwast,et al.  Pathologic features of prostate cancer found at population-based screening with a four-year interval. , 2001, Journal of the National Cancer Institute.

[17]  Nan Li,et al.  A universal pattern of mortality decline in the G7 countries , 2000, Nature.

[18]  J. Hanley,et al.  Competing risk analysis of men aged 55 to 74 years at diagnosis managed conservatively for clinically localized prostate cancer. , 1999, JAMA.

[19]  S. Yao,et al.  Population-based study of long-term survival in patients with clinically localised prostate cancer , 1997, The Lancet.

[20]  T. Wilt,et al.  The prostate cancer intervention versus observation trial (PIVOT). A randomized trial comparing radical prostatectomy versus expectant management for the treatment of clinically localized prostate cancer , 1995, Oncology.

[21]  D. Corle,et al.  Radical prostatectomy versus expectant treatment for early carcinoma of the prostate. Twenty-three year follow-up of a prospective randomized study. , 1995, Scandinavian journal of urology and nephrology. Supplementum.

[22]  C. Stocking,et al.  Sex or survival: trade-offs between quality and quantity of life. , 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.